The results demonstrate that the enhanced anti-tumor immune response in combination-treated group was accompanied by a pronounced upregulation in the expression of IFN-γ (~3.9-fold) and cytotoxic granzyme B (~2.3-fold) at the level of total tumor tissue (Figures 9J, K). The gene discussed is GZMB; the disease is neoplasm.